Solvay Pharmaceuticals, Inc. Announces New President and CEO

WOBURN, Mass.--(BUSINESS WIRE)--Dr. Stephen A. Hill, president and chief executive officer of ArQule, Inc. (NASDAQ: ARQL), has been appointed the new president and chief executive officer of Solvay Pharmaceuticals, Inc. (U.S.), as announced today by Solvay. Dr. Hill will join Solvay on April 1, 2008.

Back to news